• Follow
  • Follow
  • Follow
  • OUR EVENTS
    • PHARMA SUSTAINABILITY
      INTEGRATES
      • 2022 On Demand
      • 2022 Agenda
      • 2022 Speakers
      • 2022 Sponsors
    • BIO
      INTEGRATES
      • 2023 Agenda
      • 2023 Speakers
      • 2023 Sponsors
      • 2023 Venue
      • 2023 On Demand
      • 2023 Event Summary
      • Advisory Board
    • HEALTHTECH
      INTEGRATES
      • 2023 Agenda
      • 2023 Speakers
      • 2023 Sponsors
      • 2023 Innovator Area
      • 2023 Venue
      • 2023 On Demand
      • 2023 Event Summary
      • Advisory Board
    • PHARMATECH
      INTEGRATES
      • 2023 Agenda
      • 2023 Speakers
      • 2023 Sponsors
      • 2023 Venue
      • 2022 On Demand
      • Advisory Board
      • Register for 2023
    • PHARMA
      INTEGRATES
      • 2023 Agenda
      • 2023 Speakers
      • 2023 Sponsors
      • 2023 Venue
      • 2022 On Demand
      • Advisory Board
      • Register for 2023
    • ADVANCED THERAPIES
      INTEGRATES
      • 2023 Agenda
      • 2023 Speakers
      • 2023 Sponsors
      • 2023 Venue
      • 2022 On Demand
      • Advisory Board
      • Register for 2023
  • OTHER EVENTS
    • NSF Health Sciences Symposium
    • NSF Health Sciences Symposium Speakers
  • ABOUT US
  • LIFE SCIENCE INSIGHTS
  • SPONSOR ENQUIRY
  • CONTACT
Nanoform and Boehringer Ingelheim execute master services agreement

Nanoform and Boehringer Ingelheim execute master services agreement

by Life Science Integrates | Aug 3, 2021 | Biotech, News, Pharma, Pharmatech

Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform’s award-winning CESS® technology can deliver to its drug development projects. The...
Nanoform and Celanese Explore Ways to Enhance Drug Delivery

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

by Life Science Integrates | May 25, 2021 | Biotech, News, Pharma, Pharmatech

Together, Nanoform and Celanese will investigate the potential for enabling next-generation drug delivery devices by combining Nanoform’s nanoparticle platform technologies and Celanese’s VitalDose® EVA copolymer delivery technology.

Nanoform’s final clinical results confirm value proposition to the pharma industry

Nanoform’s final clinical results confirm value proposition to the pharma industry

by Life Science Integrates | May 18, 2021 | Biotech, News, Pharma, Pharmatech

Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study.

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

by Life Science Integrates | Apr 21, 2021 | Biotech, News, Pharma, Pharmatech

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.

Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

by Life Science Integrates | Mar 24, 2021 | Biotech, News, Pharma, Pharmatech

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP® AI (artificial intelligence) platform, v2.0.

Additional Positive Interim Results from Nanoform’s Clinical Study

Additional Positive Interim Results from Nanoform’s Clinical Study

by Life Science Integrates | Feb 24, 2021 | Biotech, News, Pharma, Pharmatech

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study.

« Older Entries
Next Entries »
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Call +44 (0) 20 8667 9551
info@lsi-uk.com

+44 (0) 20 8667 9551
info@lsi-uk.com

About Life Science Integrates
Press Enquiries
Privacy Policy
Terms & Conditions
Cookies



Nanoform and Boehringer Ingelheim execute master services agreement